Every one of those 1 sits in a single category, market-trends. Of the tracked stories, 1 of 1 also mention Idaho Department of Health and Welfare, the most common co-covered peer. Source depth averages 2 original sources per story, versus 3.6 across the same-window beat baseline.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Erythromycin Ointment
Every one of those 1 sits in a single category, market-trends. Of the tracked stories, 1 of 1 also mention Idaho Department of Health and Welfare, the most common co-covered peer. Source depth averages 2 original sources per story, versus 3.6 across the same-window beat baseline. The 5 average consequence score is below the beat benchmark of 5.9 in the same window. Erythromycin Ointment appears in 1 tracked Healthcare story from March 21, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 20 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Erythromycin Ointment. Shared-story counts are live from our verified record — not editorial picks.
A growing trend of parental refusal for essential newborn interventions, including Vitamin K injections and antibiotic eye ointments, is creating significant risks for neonatal health. This shift, fueled by medical skepticism and 'natural' parenting movements, is forcing healthcare providers to reevaluate communication strategies and legal frameworks for infant care.
